The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System.
Emanuel RaschiMichele FusaroliFrancesco MassariVeronica MollicaAndrea RepaciAndrea ArdizzoniElisabetta PoluzziUberto PagottoGuido Di DalmaziPublished in: The Journal of clinical endocrinology and metabolism (2022)
We provide a comprehensive insight into the evolution of drug-induced AI, highlighting the heterogeneous spectrum of culprit drug classes and the emerging increased reporting of ICIs. We claim for the urgent identification of predictive factors for drug-induced AI, and the establishment of screening and educational protocols for patients and caregivers.
Keyphrases
- drug induced
- liver injury
- adverse drug
- end stage renal disease
- artificial intelligence
- drug administration
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- machine learning
- emergency department
- risk assessment
- deep learning
- climate change
- patient reported
- electronic health record